A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study.
Saved in:
| Title: | A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study. |
|---|---|
| Authors: | Singh RSP; Pfizer Research and Development, Cambridge, Massachusetts, USA., Toussi SS; Pfizer Research and Development, New York, New York, USA., Hackman F; Pfizer Research and Development, Tadworth, UK., Shahbazi M; Pfizer Research and Development, New York, New York, USA., Prybylski J; Pfizer Research and Development, Groton, Connecticut, USA., Sahasrabudhe SA; Pfizer Research and Development, Cambridge, Massachusetts, USA., Crownover P; Pfizer Research and Development, Groton, Connecticut, USA., Kadar EP; Pfizer Research and Development, Groton, Connecticut, USA., George BT; Pfizer Research and Development, Groton, Connecticut, USA., Alami NN; Pfizer Research and Development, Groton, Connecticut, USA., Bergman A; Pfizer Research and Development, Groton, Connecticut, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2026 Jul; Vol. 19 (7), pp. e70659. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
